PRR13P1: A Pseudogene Targeted for Drug and Biomarker Research

Target Name: PRR13P1

NCBI ID: G647195

PRR13P1

Other Name(s): Proline rich 13 pseudogene | proline rich 13 pseudogene 1

PRR13P1: A Pseudogene Targeted for Drug and Biomarker Research

PRR13P1, also known as Pseudogene rich 13, is a gene located on chromosome 13 that has been identified as a potential drug target or biomarker. The gene is located in the genomic region between exons 265 and 269 of the APC (autosomal polygenic condition) gene on chromosome 13.

PRR13P1 is a pseudogene, which means that it is a non-coding gene that has the potential to encode a protein. The gene is named after its position on chromosome 13, and the number \"13\" in the name suggests that it is located in the 13th position on the chromosome. However, it is important to note that the gene is not actually a protein, but rather a potential target for drugs or biomarkers.

The APC gene is a known gene that has been associated with a number of genetic disorders, including Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions. The APC gene has also been implicated in the development of certain types of cancer.

PRR13P1 is located in the genomic region between exons 265 and 269 of the APC gene on chromosome 13. It is thought to be involved in the regulation of the APC gene, and is potentially involved in the development of certain genetic disorders.

One possible function of PRR13P1 is as a drug target. Drugs that target specific genes have been shown to be effective in treating a wide range of diseases, including cancer, neurodegenerative conditions, and other chronic illnesses. By targeting PRR13P1, researchers may be able to develop new treatments for a variety of conditions.

In addition to its potential as a drug target, PRR13P1 may also be a biomarker for certain diseases. Biomarkers are substances that are derived from within the body and can be used to diagnose or predict the presence of certain diseases. By studying the expression of PRR13P1, researchers may be able to develop biomarkers for a variety of conditions, including neurodegenerative diseases.

Overall, PRR13P1 is a gene that is being studied for its potential as a drug target and biomarker. While more research is needed to fully understand its role in the development of certain conditions, it is an promising area of study that could lead to new and effective treatments for a variety of diseases.

Protein Name: Proline Rich 13 Pseudogene 1

The "PRR13P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PRR13P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets